Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound

R S Foster1, R Bihrle, N Sanghvi

  • 1Department of Urology, Indiana University Medical Center, Indianapolis 46202-5250.

European Urology
|January 1, 1993
PubMed

Insights

High-intensity focused ultrasound (HIFU) effectively destroyed canine prostate tissue, creating targeted lesions with minimal damage to surrounding areas. This study supports HIFU

Area of Science:

  • Oncology
  • Medical Engineering
  • Surgical Innovation

Background:

  • High-intensity focused ultrasound (HIFU) offers non-invasive tissue ablation.
  • Transrectal ultrasound probes enable precise targeting for internal procedures.

Purpose of the Study:

  • To evaluate the feasibility of transrectal high-intensity focused ultrasound for prostate tissue ablation.
  • To assess the safety and efficacy of HIFU in a preclinical canine model.

Main Methods:

  • Development of a transrectal probe for HIFU delivery.
  • Treatment of 26 canines using the transrectal HIFU probe.
  • Histopathological examination of treated tissues.

Main Results:

  • Successful creation of coagulative necrosis lesions in target tissues.
  • Evolution of lesions into cystic cavities post-treatment.
  • Preservation of surrounding tissues with no evidence of injury.

Conclusions:

  • Transrectal high-intensity focused ultrasound is a feasible and safe method for targeted tissue ablation.
  • The technique shows promise for human clinical applications in prostate therapy.
  • HIFU enables precise destruction of diseased tissue while sparing healthy structures.

Related Concept Videos